LCE 125
Generic Name: carbidopa/entacapone/levodopa
Pill imprint LCE 125 has been identified as Stalevo 125 31.25 mg / 200 mg / 125 mg.
Stalevo 125 is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy.
Stalevo 125 31.25 mg / 200 mg / 125 mg is not subject to the Controlled Substances Act.
See also related documents.
Stalevo 125 Images
- Generic Name:
- carbidopa/entacapone/levodopa
- Imprint:
-
LCE 125
- Strength:
- 31.25 mg / 200 mg / 125 mg
- Color:
- Red
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- corn starch
croscarmellose sodium
glycerin
hypromelloses
magnesium stearate
mannitol
polysorbate 80
povidone
sucrose
ferric oxide red
titanium dioxide
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00078-0545
Advertisement
More Stalevo 125 resources
- Stalevo 125 (Cerner Multum)
- Stalevo 125 (Micromedex) - Includes Dosage Information
Search Again
